Heart Pump Device Market

Heart Pump Device Market by Product (Ventricular Assist Device (LVAD, RVAD, BiVAD, and pVAD), Intra Aortic Balloon Pump, TAH), Type (Extracorporeal and Implantable Pump), Therapy (Bridge-to-transplant, Destination Therapy) - Global Forecast to 2022

Report Code: MD 6265 May, 2018, by marketsandmarkets.com

[131 Pages Report] The global heart pump device market was valued at USD 1.32 Billion in 2016 and is projected to reach USD 3.98 Billion by 2022, at a CAGR of 19.4% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022.

Objectives of the Study

  • To define, measure, and describe the global heart pump devices market by product, type, therapy, and region
  • To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW
  • To strategically analyze the market structure and profile key players in the global heart pump device market and comprehensively analyze their core competencies
  • To track and analyze company developments such as partnerships, agreements, and collaborations; expansions; acquisitions; product approvals; and product launches in the heart pump devices market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global heart pump device market and estimate the size of other dependent submarkets. Various secondary sources such as, World Heart Federation, International Council of Cardiovascular Prevention and Rehabilitation (ICCPR), International Society for Heart and Lung Transplantation Registry for Mechanically Assisted Circulatory Support (IMACS), American Heart Association, Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS), Centers for Disease Control and Prevention (CDC), Canadian Cardiovascular Society, European Society of Cardiology, European Registry for Patients with Mechanical Circulatory Support (EUROMACS), British Society for Heart Failure, French Society of Cardiology, European Association of Percutaneous Cardiovascular Interventions (EAPCI), Asian Pacific Society of Cardiology, Japanese Registry for Mechanically Assisted Circulatory Support (J-MACS), Asian Pacific Society of Interventional Cardiology (APSIC), Dubai Health Authority (DHA), Heart Failure Society of South Africa (HeFSSA), press releases, directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Heart Pump Device Market

To know about the assumptions considered for the study, download the pdf brochure

Some of the major players in the global heart pump device market are St. Jude Medical (subsidiary of Abbott Laboratories) (US), Abiomed (US), Medtronic (Ireland), Getinge (Sweden), Teleflex (US), ReliantHeart (US), BerlinHeart (Germany), Terumo (Japan), SynCardia Systems (US), TandemLife (CardiacAssist) (US), Jarvik Heart (US), and Fresenius Medical Care (Germany).

Target Audience:

  • Manufacturers of heart pump devices
  • Original equipment manufacturers
  • Suppliers and distributors of heart pump devices
  • Healthcare service providers
  • Transplant centers
  • Teaching hospitals and academic medical centers
  • Health insurance players
  • Government bodies/municipal corporations
  • Regulatory bodies
  • Medical research institutes
  • Business research and consulting service providers
  • Venture capitalists
  • Market research and consulting firms

Scope of the Report:

The research report categorizes the heart pump device market into the following segments and subsegments:

Heart Pump Device Market, by Product

  • Ventricular Assist Devices (VADs)
    • Left Ventricular Assist Devices (LVADs)
    • Right Ventricular Assist Devices (RVADs)
    • Bi-ventricular Assist Devices (BiVADs)
    • Percutaneous Ventricular Assist Devices (pVADs)
  • Intra-aortic Balloon Pumps (IABPs)
  • Total Artificial Heart (TAH)

Heart Pump Device Market, by Type

  • Implantable Heart Pump Devices
  • Extracorporeal Heart Pump Devices

Heart Pump Device Market, by Therapy

  • Bridge-to-transplant (BTT)
  • Bridge-to-candidacy (BTC)
  • Destination Therapy (DT)
  • Other Therapies

Heart Pump Device Market, by Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Company Information

  • Detailed analysis and profiling of additional market players (up to 3)

The global heart pump devices market is projected to reach USD 3.98 Billion by 2022 from an estimated USD 1.64 Billion in 2017, at a CAGR of 19.4% during the forecast period. The growth of this market is majorly driven by factors such as growing prevalence of cardiovascular diseases, increasing number of regulatory approvals, and an acute shortage of donor hearts.

The heart pump device market is segmented on the basis of product, type, therapy, and region. Based on product, the market is segmented into ventricular assist devices, intra-aortic balloon pumps, and total artificial heart. The ventricular assist devices market is expected to grow at the highest CAGR during the forecast period. High growth in the ventricular assist devices market can be primarily attributed to the increased dependency on ventricular assist devices for the treatment of heart failure and technological advancements to improve the safety of these devices.

Based on type, the global heart pump devices market is segmented into implantable and extracorporeal heart pump devices. The implantable heart pumps segment is expected to grow at the highest CAGR during the forecast period. Technological advancements in implantable heart pump devices have made them more reliable and safe as well as improved their efficiency, thus allowing their long-term use as a survival option for patients who cannot undergo a heart transplant procedure (particularly in end-stage heart failure patients).

Based on therapy, the global heart pump device market is categorized into bridge-to-transplant, bridge-to-candidacy, destination therapy and other therapies such as bridge-to-recovery and rescue therapy. The destination therapy segment is expected to register the highest CAGR during the forecast period. The adoption of DT is likely to increase in the coming years owing to technological advancements in heart pump technology to improve their safety and efficacy and the quality of life for patients.

Geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this region can primarily be attributed to the rising prevalence of cardiovascular diseases, favorable reimbursement scenario, and the increasing number of regulatory approvals.

Heart Pump Device Market

The high cost of devices and implantation procedures and poor reimbursement scenario in developing countries is expected to restrain the growth of this market during the forecast period. For instance, in emerging countries such as China and India, no coverage is provided for heart pump devices, thus increasing the out-of-pocket expenditure by patients.

The major players in this market include St. Jude Medical (subsidiary of Abbott Laboratories) (US), Abiomed (US), Medtronic (Ireland), Getinge (Sweden), Teleflex (US), ReliantHeart (US), BerlinHeart (Germany), Terumo (Japan), SynCardia Systems (US), TandemLife (CardiacAssist) (US), Jarvik Heart (US), and Fresenius Medical Care (Germany).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
           2.1.1 Research Methodology Steps
           2.1.2 Secondary and Primary Research Methodology
                    2.1.2.1 Secondary Research
                    2.1.2.2 Primary Research
                    2.1.2.3 Key Industry Insights
           2.1.3 Key Data From Primary Sources
           2.1.4 Market Size Estimation Methodology
           2.1.5 Research Design
           2.1.6 Market Data Validation and Triangulation
           2.1.7 Assumptions for the Study

3 Executive Summary (Page No. - 27)

4 Premium Insights (Page No. - 32)
    4.1 Heart Pump Device Market Overview
    4.2 Heart Pump Devices Market, By Product, 2017 vs 2022
    4.3 Ventricular Assist Devices Market, By Vad Type, 2017 vs 2022
    4.4 Heart Pump Device Market, By Type, 2017 vs 2022
    4.5 Geographic Analysis: Heart Pump Device Market, By Therapy
    4.6 Geographic Snapshot: Heart Pump Device Market

5 Market Overview (Page No. - 37)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Prevalence of Cardiovascular Diseases
                    5.2.1.2 Regulatory Approval of Several New and Advanced Heart Pump Devices
                    5.2.1.3 Huge Gap Between the Demand and Supply of Donor Hearts
           5.2.2 Restraints
                    5.2.2.1 High Cost of Heart Pump Devices as Well as Implantation Procedures
           5.2.3 Opportunities
                    5.2.3.1 Growth Potential Offered By Emerging Countries
           5.2.4 Challenges
                    5.2.4.1 Limited Reimbursement for Heart Pump Devices for Destination Therapy

6 Heart Pump Devices Market, By Product (Page No. - 41)
    6.1 Introduction
           6.1.1 Ventricular Assist Devices
                    6.1.1.1 Left Ventricular Assist Devices
                    6.1.1.2 Right Ventricular Assist Devices
                    6.1.1.3 Bi-Ventricular Assist Devices
                    6.1.1.4 Percutaneous Ventricular Assist Devices
           6.1.2 Intra-Aortic Balloon Pumps
           6.1.3 Total Artificial Heart

7 Heart Pump Devices Market, By Type (Page No. - 50)
    7.1 Introduction
           7.1.1 Implantable Heart Pump Devices
           7.1.2 Extracorporeal Heart Pump Devices

8 Heart Pump Devices Market, By Therapy (Page No. - 55)
    8.1 Introduction
           8.1.1 Bridge-To-Candidacy (BTC)
           8.1.2 Bridge-To-Transplant (BTT)
           8.1.3 Destination Therapy (DT)
           8.1.4 Other Therapies

9 Heart Pump Devices Market, By Region (Page No. - 61)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 EU5
           9.3.2 Rest of Europe
    9.4 Asia Pacific
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 Rest of Asia Pacific
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 93)
     10.1 Overview
     10.2 Market Share Analysis
             10.2.1 St. Jude Medical (Subsidiary of Abbott Laboratories)
             10.2.2 Abiomed
             10.2.3 Medtronic
     10.3 Competitive Scenario
             10.3.1 Product Launches and Approvals
             10.3.2 Expansions
             10.3.3 Agreements, Collaborations, and Partnerships
             10.3.4 Acquisitions

11 Company Profiles (Page No. - 98)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     11.1 Abbott Laboratories
     11.2 Abiomed
     11.3 Medtronic
     11.4 Getinge
     11.5 Syncardia Systems
     11.6 Teleflex
     11.7 Reliantheart
     11.8 Terumo
     11.9 Berlin Heart
     11.10 Jarvik Heart
     11.11 Cardiacassist
     11.12 Fresenius Medical Care

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 122)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Related Reports
     12.5 Author Details


List of Tables (74 Tables)

Table 1 Heart Pump Device Market, By Product, 2015–2022 (USD Million)
Table 2 Ventricular Assist Devices Market, By Type, 2015–2022 (USD Million)
Table 3 Ventricular Assist Devices Market, By Region, 2015–2022 (USD Million)
Table 4 Left Ventricular Assist Devices Market, By Region, 2015–2022 (USD Million)
Table 5 Right Ventricular Assist Devices Market, By Region, 2015–2022 (USD Million)
Table 6 Bi-Ventricular Assist Devices Market, By Region, 2015–2022 (USD Million)
Table 7 Percutaneous Ventricular Assist Devices Market, By Region, 2015–2022 (USD Million)
Table 8 Intra-Aortic Balloon Pumps Market, By Region, 2015–2022 (USD Million)
Table 9 Total Artificial Heart Market, By Region, 2015–2022 (USD Million)
Table 10 Heart Pump Device Market, By Type, 2015–2022 (USD Million)
Table 11 Implantable Heart Pump Devices Market, By Region, 2015–2022 (USD Million)
Table 12 Extracorporeal Heart Pump Device Market, By Region, 2015–2022 (USD Million)
Table 13 Heart Pump Device Market, By Therapy, 2015–2022 (USD Million)
Table 14 Heart Pump Devices Market for Bridge-To-Candidacy Therapy, By Region, 2015–2022 (USD Million)
Table 15 Heart Pump Device Market for Bridge-To-Transplant Therapy, By Region, 2015–2022 (USD Million)
Table 16 Heart Pump Devices Market for Destination Therapy, By Region, 2015–2022 (USD Million)
Table 17 Heart Pump Device Market for Other Therapies, By Region, 2015–2022 (USD Million)
Table 18 Heart Pump Devices Market, By Region, 2015–2022 (USD Million)
Table 19 North America: Heart Pump Device Market, By Country, 2015–2022 (USD Million)
Table 20 North America: Heart Pump Devices Market, By Product, 2015–2022 (USD Million)
Table 21 North America: Ventricular Assist Devices Market, By Type, 2015–2022 (USD Million)
Table 22 North America: Heart Pump Devices Market, By Type, 2015–2022 (USD Million)
Table 23 North America: Heart Pump Devices Market, By Therapy, 2015–2022 (USD Million)
Table 24 Heart Pump Devices Approved By the Fda in 2017 & 2018
Table 25 US: Heart Pump Device Market, By Product, 2015–2022 (USD Million)
Table 26 US: Ventricular Assist Devices Market, By Type, 2015–2022 (USD Million)
Table 27 US: Heart Pump Devices Market, By Design, 2015–2022 (USD Million)
Table 28 US: Heart Pump Devices Market, By Therapy, 2015–2022 (USD Million)
Table 29 Canada: Heart Pump Device Market, By Product, 2015–2022 (USD Million)
Table 30 Canada: Ventricular Assist Devices Market, By Type, 2015–2022 (USD Million)
Table 31 Canada: Heart Pump Devices Market, By Design, 2015–2022 (USD Million)
Table 32 Canada: Heart Pump Devices Market, By Therapy, 2015–2022 (USD Million)
Table 33 Europe: Heart Pump Device Market, By Region, 2015–2022 (USD Million)
Table 34 Europe: Heart Pump Devices Market, By Product, 2015–2022 (USD Million)
Table 35 Europe: Ventricular Assist Devices Market, By Type, 2015–2022 (USD Million)
Table 36 Europe: Heart Pump Devices Market, By Design, 2015–2022 (USD Million)
Table 37 Europe: Heart Pump Devices Market, By Therapy, 2015–2022 (USD Million)
Table 38 EU5: Heart Pump Device Market, By Product, 2015–2022 (USD Million)
Table 39 EU5: Ventricular Assist Devices Market, By Type, 2015–2022 (USD Million)
Table 40 EU5: Heart Pump Devices Market, By Design, 2015–2022 (USD Million)
Table 41 EU5: Heart Pump Devices Market, By Therapy, 2015–2022 (USD Million)
Table 42 RoE: Heart Pump Device Market, By Product, 2015–2022 (USD Million)
Table 43 RoE: Ventricular Assist Devices Market, By Type, 2015–2022 (USD Million)
Table 44 RoE: Heart Pump Devices Market, By Design, 2015–2022 (USD Million)
Table 45 RoE: Heart Pump Devices Market, By Therapy, 2015–2022 (USD Million)
Table 46 Asia Pacific: Heart Pump Device Market, By Country, 2015–2022 (USD Million)
Table 47 Asia Pacific: Heart Pump Devices Market, By Product, 2015–2022 (USD Million)
Table 48 Asia Pacific: Ventricular Assist Devices Market, By Type, 2015–2022 (USD Million)
Table 49 Asia Pacific: Heart Pump Devices Market, By Design, 2015–2022 (USD Million)
Table 50 Asia Pacific: Heart Pump Devices Market, By Therapy, 2015–2022 (USD Million)
Table 51 Japan: Heart Pump Device Market, By Product, 2015–2022 (USD Million)
Table 52 Japan: Ventricular Assist Devices Market, By Type, 2015–2022 (USD Million)
Table 53 Japan: Heart Pump Devices Market, By Type, 2015–2022 (USD Million)
Table 54 Japan: Heart Pump Devices Market, By Therapy, 2015–2022 (USD Million)
Table 55 China: Heart Pump Device Market, By Product, 2015–2022 (USD Million)
Table 56 China: Ventricular Assist Devices Market, By Type, 2015–2022 (USD Million)
Table 57 China: Heart Pump Devices Market, By Type, 2015–2022 (USD Million)
Table 58 China: Heart Pump Devices Market, By Therapy, 2015–2022 (USD Million)
Table 59 India: Heart Pump Device Market, By Product, 2015–2022 (USD Million)
Table 60 India: Ventricular Assist Devices Market, By Type, 2015–2022 (USD Million)
Table 61 India: Heart Pump Devices Market, By Type, 2015–2022 (USD Million)
Table 62 India: Heart Pump Devices Market, By Therapy, 2015–2022 (USD Million)
Table 63 RoAPAC: Heart Pump Device Market, By Product, 2015–2022 (USD Million)
Table 64 RoAPAC: Ventricular Assist Devices Market, By Type, 2015–2022 (USD Million)
Table 65 RoAPAC: Heart Pump Devices Market, By Type, 2015–2022 (USD Million)
Table 66 RoAPAC: Heart Pump Devices Market, By Therapy, 2015–2022 (USD Million)
Table 67 RoW: Heart Pump Device Market, By Product, 2015–2022 (USD Million)
Table 68 RoW: Ventricular Assist Devices Market, By Type, 2015–2022 (USD Million)
Table 69 RoW: Heart Pump Devices Market, By Type, 2015–2022 (USD Million)
Table 70 RoW: Heart Pump Devices Market, By Therapy, 2015–2022 (USD Million)
Table 71 Product Launches and Approvals
Table 72 Expansions
Table 73 Agreements, Collaborations, and Partnerships
Table 74 Acquisitions


List of Figures (33 Figures)

Figure 1 Global Heart Pump Devices Market: Research Methodology Steps
Figure 2 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Ventricular Assist Devices Dominated the Heart Pump Devices Market in 2017
Figure 7 Left Ventricular Assist Devices Dominated the Market in 2017
Figure 8 Implantable Heart Pump Devices Dominated the Heart Pump Devices Market, By Type, in 2017
Figure 9 Bridge-To-Candidacy Therapy Dominated the Heart Pump Device Market in 2017
Figure 10 North America to Witness the Highest Growth During the Forecast Period
Figure 11 Growing Prevalence of Cardiovascular Diseases to Drive Market Growth
Figure 12 Ventricular Assist Devices Dominated the Market in 2017
Figure 13 Left Ventricular Assist Devices Accounted for the Largest Market Share in 2017
Figure 14 Implantable Heart Pump Devices Dominated the Market in 2017
Figure 15 Bridge-To-Candidacy Segment Dominated the Global Heart Pump Devices Market in 2017
Figure 16 North America to Witness the Highest Growth During the Forecast Period
Figure 17 Heart Pump Devices Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Heart Pump Devices Market, By Product
Figure 19 Heart Pump Devices Market, By Type, 2017 vs 2022 (USD Million)
Figure 20 Heart Pump Devices Market, By Therapy
Figure 21 North America to Command the Largest Market Share in 2017
Figure 22 North America: Heart Pump Device Market Snapshot
Figure 23 Europe: Heart Pump Device Market Snapshot
Figure 24 Asia Pacific: Heart Pump Device Market Snapshot
Figure 25 Rest of the World: Heart Pump Device Market Snapshot
Figure 26 Heart Pump Devices Market Share, By Key Player, 2016
Figure 27 Strategies Adopted By Market Players (2014–2017)
Figure 28 Abiomed: Company Snapshot (2017)
Figure 29 Medtronic: Company Snapshot (2016)
Figure 30 Getinge: Company Snapshot (2016)
Figure 31 Teleflex: Company Snapshot (2017)
Figure 32 Terumo: Company Snapshot (2016)
Figure 33 Fresenius Medical Care: Company Snapshot (2017)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 6265
Published ON
May, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Heart Pump Device Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved